|
|
|
Volumn 74, Issue 9, 2003, Pages 729-735
|
|
Role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 with concurrent HPV infection;Wpływ leczenia Iscadorem QuS i interferonem alfa (Intron A) na przebieg srodnabłonkowej neoplazji szyjki macicy (CIN1 i CIN2) z towarzyszaca infekcja wirusem ludzkiego brodawczaka (HPV).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
IMMUNOLOGICAL ADJUVANT;
PLANT EXTRACT;
VEGETABLE PROTEIN;
VISCUM ALBUM PEPTIDE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COLPOSCOPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MIDDLE AGED;
PAPILLOMA VIRUS;
REMISSION;
TIME;
TREATMENT OUTCOME;
UTERINE CERVIX CARCINOMA IN SITU;
UTERINE CERVIX TUMOR;
VIROLOGY;
VIRUS INFECTION;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTIVIRAL AGENTS;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
COLPOSCOPY;
FEMALE;
HUMANS;
INTERFERON ALFA-2B;
MIDDLE AGED;
PAPILLOMAVIRIDAE;
PAPILLOMAVIRUS INFECTIONS;
PLANT EXTRACTS;
PLANT PROTEINS;
REMISSION INDUCTION;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR VIRUS INFECTIONS;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 1542751069
PISSN: 00170011
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
